All Report
Whether you’re exploring new opportunities, responding to change, or planning your next move—we’re here to help you make sense of it all. Our research goes beyond data to uncover real market signals, emerging trends, competitive shifts, and what they mean for your business. With practical insights and a partner mindset, we support you in making smarter, faster, and more confident decisions.
The peptide drug conjugates market is expected to experience significant growth, reaching USD 6.33 billion by 2035, up from USD 1.86 billion in 2025. The market is projected to expand at a CAGR of 21%
The global peptide receptor radionuclide therapy (PRRT) market is projected to grow significantly, from USD 592.83 million in 2024 to USD 1.4 billion by 2034, at an impressive compound annual growth rate (CAGR) of 9.2%
The rheumatic heart disease management market is projected to witness steady growth, with an estimated market size of USD 2.32 billion by 2035, up from USD 1.32 billion in 2025. This reflects a CAGR of 5.5%
The global ringworm treatment market is poised for substantial growth, reaching USD 14.91 billion by 2035, up from USD 9.38 billion in 2025, reflecting an estimated CAGR of 6.2%
The global market for RNA-targeted small molecules is projected to experience substantial growth, fueled by increasing investments in RNA-targeted therapies. The market, valued at USD 2,454.5 million in 2025, is expected to reach USD 5,311.7 million by 2035, expanding at a CAGR of 7.3%
The global robot-assisted surgical microscope market is projected to expand from USD 411.6 million in 2024 to USD 859.0 million by 2034, growing at a compound annual growth rate (CAGR) of 8.6%
The global robotic biopsy devices market is poised for remarkable growth, projected to expand from USD 441.2 million in 2024 to USD 1,073.3 million by 2034, achieving a compound annual growth rate (CAGR) of 10.3%
The global robotic lung biopsy market is set for substantial growth, with an estimated valuation of USD 409.0 million in 2025, projected to reach USD 2,024.05 million by 2035 at a CAGR of 10.6%.
The global robotic wheelchair market is anticipated to grow from USD 157.4 million in 2024 to USD 452.1 million by 2034, reflecting a compound annual growth rate (CAGR) of 12.1%
The Robotic-Assisted Endovascular Systems Market is projected to reach USD 95.0 million in 2025, with a significant surge expected, surpassing USD 215.7 million by 2035, growing at a CAGR of 9.6%